Reference:
20240894
Release date: 11 December 2025
Release date: 11 December 2025
Promoter – Financial Intermediary
SQIM SRLLocation
Description
The project will finance capital expenditures (CAPEX) for the industrialization of mycelium-based materials production in Italy. It will also fund research and development activities, along with other expenses for the period 2025–2028, to support the company’s growth.
Objectives
The aim is to develop innovative biotechnology and biomaterials that make a significant contribution to the objectives of the Green Deal.
Sector(s)
- Industry - Manufacturing
Proposed EIB finance (Approximate amount)
EUR 15 million
Total cost (Approximate amount)
EUR 34 million
Environmental aspects
Final beneficiaries will be requested to comply with applicable national and EU legislation, as appropriate.
Procurement
Final beneficiaries will be requested to comply with applicable national and EU legislation, as appropriate.
Status
Signed - 3/12/2025
Milestone
Under appraisal
Approved
Signed
7 August 2025
3 December 2025